Send us Feedback

SciClone Pharmaceuticals (SCLN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

SCLN » Topics » FORM 10-Q

This excerpt taken from the SCLN 10-Q filed May 11, 2009.

FORM 10-Q

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2009

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 0-19825

This excerpt taken from the SCLN 10-Q filed Nov 6, 2008.

FORM 10-Q

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2008

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 0-19825

This excerpt taken from the SCLN 10-Q filed Aug 1, 2008.

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2008

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________________to ______________________

Commission file number: 0-19825

This excerpt taken from the SCLN 10-Q filed May 8, 2008.

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2008

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number: 0-19825

This excerpt taken from the SCLN 10-Q filed Nov 9, 2007.

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2007

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 0-19825

EXCERPTS ON THIS PAGE:

10-Q
May 11, 2009
10-Q
Nov 6, 2008
10-Q
Aug 1, 2008
10-Q
May 8, 2008
10-Q
Nov 9, 2007

RELATED TOPICS for SCLN:

"FORM 10-Q" elsewhere:

Adolor (ADLR)
Allos Therapeutics (ALTH)
Alexion Pharmaceuticals (ALXN)
Arena Pharmaceuticals (ARNA)
ArQule (ARQL)
Sarepta Therapeutics, Inc. (AVII)
Cubist Pharmaceuticals (CBST)
Cephalon (CEPH)
CoreSite Realty Corp (COR)
DepoMed (DEPO)
Durect (DRRX)
Dynavax Technologies (DVAX)
ENDO HEALTH SOLUTIONS INC. (ENDP)
Geron (GERN)
Isis Pharmaceuticals (ISIS)
Inspire Pharmaceuticals (ISPH)
Lannett Co (LCI)
Ligand Pharmaceuticals (LGND)
Medicines Company (MDCO)
NeurogesX (NGSX)
NitroMed (NTMD)
PDL BioPharma (PDLI)
Pozen (POZN)
Pain Therapeutics (PTIE)
RELIV INTERNATIONAL INC (RELV)
Sunovion Pharmaceuticals Inc. (SEPR)
SIGA Technologies (SIGA)
Astex Pharmaceuticals, Inc (SUPG)
United Therapeutics (UTHR)
Valeant Pharmaceuticals International (VRX)
Warner Chilcott (WCRX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki